Prevalence of total, acquired and ART-adjusted HIV drug resistance.

A: Prevalence of total drug resistance at 2018. B: Prevalence of total drug resistance by 2030. C: Prevalence of acquired drug resistance mutations by 2030. D: Prevalence of acquired drug-resistant mutants by 2030. E: Prevalence of acquired drug-resistant mutants at 2018. F: ART-adjusted drug resistance prevalence at 2018.